Abstract
Cost-effectiveness analyses (CEA) are important in healthcare decision-making and resource allocation for assessing costs and benefits of new treatments in terms of clinical efficiency. Expanding value elements, such as health equity, for new technologies in traditional CEAs has attracted interest. This study synthesized evidence on how equity concepts were considered in modified CEAs by conducting an umbrella review of systematic literature reviews (SLR).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
